Clinical trial
Outpatient Laser Ablation of Recurrent Non-muscle Invasive Bladder Cancer
NCT05337397 is registered in ClinicalTrials.gov with Jørgen Bjerggaard Jensen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Outpatient Laser Ablation of Recurrent Non-muscle Invasive Bladder Cancer
- Lead sponsor
- Jørgen Bjerggaard Jensen
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 1, 2022
- Completion date
- April 1, 2027
- Enrollment
- 145 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non-muscle invasive bladder cancer